Kolexia
Pflumio Carole Oncologie médicale
Pflumio Carole
Oncologie médicale
Centre Paul Strauss
Strasbourg, France
62 Activités
8 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Carcinome épidermoïde Métastase tumorale Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Métastases d'origine inconnue Récidive tumorale locale Métastase lymphatique

Collaborateurs

Voir plus
Pivot Xavier
Pivot Xavier
Centre Paul Strauss, Strasbourg, France
Trensz Philippe
Trensz Philippe
Hôpital Hautepierre, Strasbourg, France
Faivre Jean-Christophe
Faivre Jean-Christophe
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Kalish Michal
Kalish Michal
Centre Paul Strauss, Strasbourg, France

Industries

Voir plus
Lilly
10 collaboration(s)
Dernière en 2023
Novartis
6 collaboration(s)
Dernière en 2023
Pfizer
4 collaboration(s)
Dernière en 2023
Seagen
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.
Journal of cachexia, sarcopenia and muscle   06 janvier 2024
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC cancer   08 décembre 2023
IPRICE: Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
Essai Clinique (Institut de cancérologie Strasbourg Europe)   21 septembre 2023
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
Cancer treatment and research communications   25 juin 2023
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.
European journal of applied physiology   20 mars 2023
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.
Breast cancer research and treatment   23 décembre 2022
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
Cancer   17 novembre 2022
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
Clinical breast cancer   13 octobre 2022
Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy.
American journal of physiology. Cell physiology   12 septembre 2022
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients.
Journal of cachexia, sarcopenia and muscle   04 avril 2022